Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off ...

Mankind Pharma has launched its affordable generic version empagliflozin in India for diabetes following its patent expiration. The launch follows patent expiration of empagliflozin sold by German ...

The maker of popular Manforce condoms and Prega News pregnancy test kits, Mankind Pharma, is developing an oral anti-obesity drug that, if successful, could become the first small-molecule ...

What was the problem you were grappling with? As Mankind grew, we faced a critical challenge-our once-celebrated speed of execution began to slow. The increasing complexity in our structure led to ...

Rajeev Juneja, Vice-Chairman and Managing Director, Mankind Pharma (Image Credits: FE.com) Boehringer Ingelheim’s blockbuster diabetes Drug Empagliflozin is now off-patent in India. On Wednesday ...

Mankind Pharma divests stake in Mahananda Spa to Chalet Hotels at Rs 530 crore Enterprise Value The Share Purchase Agreement will be executed soon, said Mankind Pharma, and the transaction will be ...

Zealand Pharma (ZLDPF) announced that the last participant has been enrolled and randomized to active treatment or placebo in ZUPREME-1, a global Phase 2b trial in people with obesity or ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

Mankind Pharma has launched generic versions of diabetes medication Empagliflozin under brand names Empaglyde, Empagreat, and Dynaduo, offering affordable treatment options. New Delhi, Mar 12 (PTI) ...

Rajeev Juneja, vice chairman and managing director of Mumbai, Indian-based drugmaker Mankind Pharma (NSE: MANKIND), today announced that the company is launching the generic version as well as its ...

At present, US has no tariffs levied on drug imports from India, while India imposes about 10 percent tariff on pharma imports from the US. India is the largest global supplier of generic ...